A detailed history of Applied Finance Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 233,467 shares of ABBV stock, worth $41.3 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
233,467
Previous 20,147 1058.82%
Holding current value
$41.3 Million
Previous $3.46 Billion 1128.07%
% of portfolio
1.81%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $34.4 Million - $41.8 Million
-209,869 Reduced 89.89%
23,598 $4.66 Billion
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $35 Million - $42.5 Million
213,320 Added 1058.82%
233,467 $42.4 Billion
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $2.82 Million - $3.3 Million
18,234 Added 953.16%
20,147 $3.46 Billion
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $305,735 - $348,357
1,913 New
1,913 $348 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Applied Finance Capital Management, LLC Portfolio

Follow Applied Finance Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Applied Finance Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Applied Finance Capital Management, LLC with notifications on news.